Biomarker: F036-IgE Coconut

Overview

F036-IgE Coconut measures serum allergen-specific immunoglobulin E (sIgE) antibodies directed against coconut (Cocos nucifera). IgE is involved in immediate hypersensitivity reactions, including urticaria, gastrointestinal symptoms, respiratory symptoms, and anaphylaxis. A detectable or elevated result indicates sensitization and may support coconut allergy when consistent with a relevant clinical history, while a low or undetectable result reduces but does not eliminate the possibility of allergy. The test is clinically useful for evaluating suspected IgE-mediated coconut allergy, but the result alone does not confirm allergy or predict reaction severity.

Clinical Use Cases

Evaluation of suspected immediate allergic reactions after ingestion or exposure to coconut, coconut milk, coconut water, coconut oil, or coconut-containing products.
Identification of coconut sensitization as part of an allergy-focused evaluation.
Support for diagnosing IgE-mediated coconut allergy when interpreted with clinical history and, when necessary, skin-prick testing or a medically supervised oral food challenge.
Assessment of possible coconut allergy in patients with reactions involving the skin, gastrointestinal tract, respiratory system, or more than one organ system.
Research into the clinical characteristics and allergen-specific IgE profiles of coconut allergy.

Specimen Types

Serum collected from venous blood.
Plasma, including EDTA or heparin plasma, may be validated for some assay platforms.

Measurement Methods

Fluorescence enzyme immunoassay, including ImmunoCAP-based methods.
Other validated automated or manual immunoassays for allergen-specific IgE.
The assay generally immobilizes coconut allergen extract, binds patient sIgE, and detects bound IgE using a labeled anti-human IgE antibody.
Skin-prick testing and oral food challenge are complementary clinical procedures, not specimen-based measurement methods.

Test Preparation and Influencing Factors

Fasting is generally not required for serum-specific IgE testing.
Antihistamines generally do not affect blood-specific IgE measurement, although they can suppress skin-prick test responses.
Patients should report all medications, supplements, and biologic therapies to the ordering clinician because medication effects may depend on the testing method and clinical context.
Collection timing is usually not restricted, but results should be interpreted in relation to the timing, amount, and form of coconut exposure and the symptoms observed.
Total IgE concentration, age, atopic conditions, and assay characteristics can influence interpretation.
A positive result indicates sensitization and does not by itself establish clinically relevant allergy.
The numerical sIgE concentration does not reliably predict the severity of a future reaction.
Low-level positive results may be difficult to interpret and can occur without clinical reactivity.
Oral food challenges should be performed only under appropriate medical supervision because coconut exposure can cause anaphylaxis in sensitized individuals.